Ruste, Rhianna .

HRN: 28-98-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/02/2026
06/09/2026
IV
52mg
Q8H
Amoebiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines